Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

1,001 public trials 299 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Completed

Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer

NCT00071929

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • CCOP - Western Regional, Arizona Phoenix, Arizona, United States
  • Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center Orange, California, United States
  • University of Colorado Cancer Center at University of Colorado Health Sciences Center Denver, Colorado, United States
View all 38 locations
View Trial Details
Completed

Thalidomide in Treating Patients With Gynecologic Sarcomas

NCT00006005

Conditions
Endometrial Cancer, Endometrial Neoplasms, Endometrial Stromal Tumors, +16 more
Locations
  • Cancer Center of Albany Medical Center Albany, New York, United States
  • North Shore University Hospital Manhasset, New York, United States
  • St. Vincent's Comprehensive Cancer Center New York, United States
  • NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, United States
View Trial Details
Completed

Chemotherapy in Treating Patients With Sarcoma of the Uterus

NCT00005643

Conditions
Endometrial Cancer, Endometrial Neoplasms, Endometrial Stromal Tumors, +16 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Community Hospital of Los Gatos Los Gatos, California, United States
View all 49 locations
View Trial Details
Completed

Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer

NCT00003946

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
View all 73 locations
View Trial Details
Completed

Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer

NCT00005861

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • New England Medical Center Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer

NCT00005031

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • Community Hospital of Los Gatos Los Gatos, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
View all 40 locations
View Trial Details

Related conditions